Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Torres

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of the National Cancer Institute|April 2, 2025
A randomized study of 2 risk assessment models for individualized breast cancer risk estimationAdrià López-Fernández, Laura Duran-Lozano, Guillermo Villacampa, et al.
Nature Communications|July 10, 2020
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalAlberto L Garcia-Basteiro, Gemma Moncunill, Marta Tortajada, et al.
The Journal of Infectious Diseases|November 11, 2020
SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-upGemma Moncunill, Alfredo Mayor, Rebeca Santano, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
Human Mutation|May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationMichael T Parsons, Emma Tudini, Hongyan Li, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of the National Cancer Institute|April 2, 2025
A randomized study of 2 risk assessment models for individualized breast cancer risk estimationAdrià López-Fernández, Laura Duran-Lozano, Guillermo Villacampa, et al.
Nature Communications|July 10, 2020
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalAlberto L Garcia-Basteiro, Gemma Moncunill, Marta Tortajada, et al.
The Journal of Infectious Diseases|November 11, 2020
SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-upGemma Moncunill, Alfredo Mayor, Rebeca Santano, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
Human Mutation|May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationMichael T Parsons, Emma Tudini, Hongyan Li, et al.
Pageof 9